Kathleen L Grady1, David C Naftel2, Susan Myers2, Annetine Gelijins3, Alan Moskowitz4, Francis D Pagani5, James B Young6, John A Spertus7, James K Kirklin2. 1. Division of Cardiac Surgery, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Electronic address: kgrady@nmh.org. 2. Department of Surgery, University of Alabama, Birmingham, Birmingham, Alabama. 3. Department of Population Health Science and Policy, Mount Sinai Medical Center, New York, New York. 4. Departments of Medicine and Population Health Science and Policy, Mount Sinai Medical Center, New York, New York. 5. Department of Surgery, University of Michigan, Ann Arbor, Michigan. 6. Department of Medicine, Cleveland Clinic Foundation Lerner College of Medicine, Cleveland, Ohio. 7. Division of Cardiovascular Research, St. Luke's Mid America Heart Institute, St. Luke's Mid America Heart Institute and University of Missouri Kansas City, Kansas City, Missouri.
Abstract
BACKGROUND: Gaps in the literature exist regarding health-related quality of life (HRQOL) early after left ventricular assist device (LVAD) surgery. The purposes of our study were to describe HRQOL over time, by age and gender, and identify risk factors for poor HRQOL early after LVAD implant. METHODS: Patients (n = 7,353) from the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database received a continuous-flow LVAD as a primary implant at 133 United States hospitals. Of these, 5,640 patients had pre-LVAD HRQOL data, 3,353 patients had 6-month post-LVAD HRQOL data, and 2,748 patients had data at both times. HRQOL was measured using the EQ-5D-3L (Euro-Qol) instrument. Data were collected pre-implant and 3 and 6 months post-operatively. Statistical analyses included chi-square test, t-test, Pearson correlation coefficients, and multiple regression analysis. RESULTS: Overall HRQOL and dimensions of HRQOL improved from before to 6 months after device implant when examined by age and gender. However, younger patients and women reported significantly more problems regarding all dimensions before implant and significantly more problems regarding pain/discomfort and anxiety/depression at 3 and 6 months after implant. An increase in overall HRQOL from before to 6 months after implant was related to pre-implant INTERMACS Level 1. Factors related to a decrease in HRQOL from before to 6 months after implant were listed for heart transplant before surgery, comorbidities, better preoperative HRQOL, adverse events within 6 months after implant, bridge to transplant moderately likely and unlikely, and New York Heart Association Functional Classification IV at 6 months after LVAD (R(2) = 41%). CONCLUSIONS: Overall HRQOL and dimensions of HRQOL improve in sub-groups of patients from before to 6 months after surgery, although differences in improvement exist. Adverse events are risk factors for decreased HRQOL across time and support the ongoing need to improve device technology with the aim of reducing adverse events.
BACKGROUND: Gaps in the literature exist regarding health-related quality of life (HRQOL) early after left ventricular assist device (LVAD) surgery. The purposes of our study were to describe HRQOL over time, by age and gender, and identify risk factors for poor HRQOL early after LVAD implant. METHODS:Patients (n = 7,353) from the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database received a continuous-flow LVAD as a primary implant at 133 United States hospitals. Of these, 5,640 patients had pre-LVAD HRQOL data, 3,353 patients had 6-month post-LVAD HRQOL data, and 2,748 patients had data at both times. HRQOL was measured using the EQ-5D-3L (Euro-Qol) instrument. Data were collected pre-implant and 3 and 6 months post-operatively. Statistical analyses included chi-square test, t-test, Pearson correlation coefficients, and multiple regression analysis. RESULTS: Overall HRQOL and dimensions of HRQOL improved from before to 6 months after device implant when examined by age and gender. However, younger patients and women reported significantly more problems regarding all dimensions before implant and significantly more problems regarding pain/discomfort and anxiety/depression at 3 and 6 months after implant. An increase in overall HRQOL from before to 6 months after implant was related to pre-implant INTERMACS Level 1. Factors related to a decrease in HRQOL from before to 6 months after implant were listed for heart transplant before surgery, comorbidities, better preoperative HRQOL, adverse events within 6 months after implant, bridge to transplant moderately likely and unlikely, and New York Heart Association Functional Classification IV at 6 months after LVAD (R(2) = 41%). CONCLUSIONS: Overall HRQOL and dimensions of HRQOL improve in sub-groups of patients from before to 6 months after surgery, although differences in improvement exist. Adverse events are risk factors for decreased HRQOL across time and support the ongoing need to improve device technology with the aim of reducing adverse events.
Authors: James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2014-04-21 Impact factor: 10.247
Authors: Mary Amanda Dew; Andrea F DiMartini; Annette J DeVito Dabbs; Kristen R Fox; Larissa Myaskovsky; Donna M Posluszny; Galen E Switzer; Rachelle A Zomak; Robert L Kormos; Yoshiya Toyoda Journal: Gen Hosp Psychiatry Date: 2012-01-14 Impact factor: 3.238
Authors: Debra K Moser; Seongkum Heo; Kyoung Suk Lee; Muna Hammash; Barbara Riegel; Terry A Lennie; Cynthia Arslanian-Engoren; Gia Mudd-Martin; Nancy Albert; John Watkins Journal: Age Ageing Date: 2013-07-05 Impact factor: 10.668
Authors: Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier Journal: N Engl J Med Date: 2009-11-17 Impact factor: 91.245
Authors: Manal Alasnag; Alexander G Truesdell; Holli Williams; Sara C Martinez; Syeda Kashfi Qadri; John P Skendelas; William A Jakobleff; Mirvat Alasnag Journal: Curr Atheroscler Rep Date: 2020-04-23 Impact factor: 5.113
Authors: Windy W Alonso; Kenneth M Faulkner; Bunny J Pozehl; Judith E Hupcey; Lisa A Kitko; Christopher S Lee Journal: Res Nurs Health Date: 2020-07-06 Impact factor: 2.228
Authors: Jeffrey H Barsuk; Jane E Wilcox; Elaine R Cohen; Rebecca S Harap; Kerry B Shanklin; Kathleen L Grady; Jane S Kim; Gretchen P Nonog; Lauren E Schulze; Alison M Jirak; Diane B Wayne; Kenzie A Cameron Journal: Circ Cardiovasc Qual Outcomes Date: 2019-10-11
Authors: Garrick C Stewart; Thomas Cascino; Blair Richards; Shokoufeh Khalatbari; Douglas L Mann; Wendy C Taddei-Peters; J Timothy Baldwin; Neal O Jeffries; Catherine Spino; Lynne W Stevenson; Keith D Aaronson Journal: JACC Heart Fail Date: 2019-05-08 Impact factor: 12.035
Authors: Quin E Denfeld; Christopher S Lee; William R Woodward; Shirin O Hiatt; James O Mudd; Beth A Habecker Journal: J Cardiovasc Nurs Date: 2019 Jul/Aug Impact factor: 2.083
Authors: Kathleen L Grady; Philip G Jones; Adin Cristian-Andrei; David C Naftel; Susan Myers; Mary Amanda Dew; Katharine Idrissi; Gerdi Weidner; Sherri A Wissman; James K Kirklin; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2017-12
Authors: Josef Stehlik; Maria Mountis; Donald Haas; Maryse Palardy; Amrut V Ambardekar; Jerry D Estep; Gregory Ewald; Stuart D Russell; Shawn Robinson; Ulrich Jorde; Wendy C Taddei-Peters; Neal Jeffries; Blair Richards; Shokoufeh Khalatbari; Catherine Spino; J Timothy Baldwin; Douglas Mann; Garrick C Stewart; Keith D Aaronson Journal: J Heart Lung Transplant Date: 2019-11-20 Impact factor: 10.247
Authors: Zeliha Özdemir Köken; Ümit Kervan; Murat Avşar; Sinan Sabit Kocabeyoğlu; Mustafa Paç Journal: Turk Gogus Kalp Damar Cerrahisi Derg Date: 2020-04-22 Impact factor: 0.332